Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.47 USD | -1.33% | -6.29% | -29.84% |
09-10 | Arrowhead Pharmaceuticals' Plozasiran Receives FDA Breakthrough Therapy Designation | MT |
09-10 | Arrowhead Pharmaceuticals Gets FDA Breakthrough Designation for Plozasiran | DJ |
MarketScreener is also available in this country: United States.
Switch edition